1. Abdurasulova, I. N., Ekimova, I. V., Chernyshev, M. V., et al., “Impaired cognitive functions in Wistar rats in a model of the preclinical stage of Parkinson’s disease,” Zh. Vyssh. Nerv. Deyat., 69, No. 3, 364–381 (2019).
2. Aftanas, L. I., Gevorgyan, M. M., Zhanaeva, S. Y., et al., “Therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) on neuroinflammation and neuroplasticity in patients with Parkinson’s disease: a placebo-controlled study,” Bull. Exp. Biol. Med., 165, 195–199 (2018).
3. Ahn, J. J., Abu-Rub, M., and Miller, R. H., “B cells in neuroinflammation: New Perspectives and mechanistic insights,” Cells, 10, No. 7, 1605 (2021).
4. Akhtar, R. S., Licata, J. P., Luk, K. C., et al., “Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson’s disease,” J. Neurochem., 145, No. 6, 489–503 (2018).
5. Alperina, E. L., Contribution of the dopaminergic system to the mechanisms of immunomodulation,” Usp. Fiziol. Nauk., 45, No. 3, 45–56 (2014).